McKesson buys specialty distributor

Article Excerpt

MCKESSON CORP. $146 (New York symbol MCK; Aggressive Growth Portfolio, Consumer sector; Shares outstanding: 208.5 million; Market cap: $30.4 billion; Price-to-sales ratio: 0.2; Dividend yield 0.9%; TSINetwork Rating: Above Average; www.mckesson.com) is the largest wholesale drug distributor in the U.S. and Canada. The company has agreed to acquire RxCrossroads from CVS Health Corp. (New York symbol CVS). That business sells logistics and dispensing services to pharmaceutical drug makers. McKesson will pay $735 million to complete the deal in early 2018. The operations should add $0.20 a share to its annual earnings by the end of the third year. The company earned $12.91 a share for the year ended March 31, 2017. However, expanding by acquisition adds risk. McKesson is a hold. hold…